Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chung, Seyung S ^a   Aroh, Clement ^a   Vadgama, Jaydutt V ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NF-KAPPA B; PHENOTYPE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TELOMERASE; UP-REGULATION;

EID: 84893530696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083971     Document Type: Article

References (38)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Mitra I (2011) Breast cancer screening in developing countries. Prev Med 53: 121-122.
3. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
4. Rathone K, Wang HC (2013) Mesenchymal and stem-like cell targeting in suppression of chronically induced breast carcinogenesis. Cancer Letter 333: 113-123.
5. Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, et al. (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44(+) CD24(-) stem cell-like breast cancer cells in human tumors. J Clin Invest 121: 2723-2735.
6. Shostak K, Chariot A (2011) NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 13: 214.
7. Zhong Z, Wen Z, Darnell JE (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98. (Pubitemid 24144493)
8. Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19: 6613-6626. (Pubitemid 32197700)
9. Azare J, Doane A, Leslie K, Chang Q, Berishaj M, et al. (2011) STAT3 mediates expression of autotaxin in breast cancer. PLOS One 6: e27861.
10. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, et al. (2005) STAT3 regulates genes common both wound healing and cancer. Oncogene 24: 3397-3408. (Pubitemid 40756241)
11. Yang CH, Shi W, Basu L, Murti A, Constantinescu SN, et al. (1996) Direct association of STAT3 with theIFNAR1 signal transducing chain of the type I IFN receptor. J Biol Chem 271: 8057-8061. (Pubitemid 26108627)
12. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-238.
13. Beg AA, Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782-784. (Pubitemid 26398258)
14. Van-Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-α-induced apotosis by NF-κB. Science 274: 787-789.
15. Wang CY, Mayo MW, Baldwin Jr AS (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-787. (Pubitemid 26398259)
16. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, et al. (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTERT. Nat Genet 17: 498-502. (Pubitemid 27518407)
17. Kirkpatrick KL, Mokbel K (2001) The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol 278: 754-760. (Pubitemid 33085546)
18. Kyo S, Takakura M, Fujiwara T, Inoue M (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci. 99: 1528-1538.
19. Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, et al. (2006) hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. Cancer Res 66: 3531-3540.
20. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, et al. (1998) Telomerase activation by hTERT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18: 65-68. (Pubitemid 28027882)
21. Glukhov AI, Svinareva LV, Severin SE, Shvets VI (2011) Telomerase inhibitors as novel antitumour drugs. Applied Biochemistry and Microbiology 47: 655-660.
22. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG (1995) Telomerase activity in oncogenesis in giant cell tumor of bone. Cancer 75: 1094-1099.
23. Urquidi V, Tarin D, Goodison S (2000) Role of telomerase in cell senescence and oncogenesis. Annual Rev Med 51: 65-79. (Pubitemid 30216026)
24. Blasco MA, Hahn WC (2003) Evolving views of telomerase and cancer. Trend in Cell Biol 13: 289-294. (Pubitemid 36638795)
25. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al. (2002) Telomerase contribute to tumorigenesis by a telomere length independent mechanism. Proc Nat Acad Sci 99: 12606-12611.
26. Liu Z, Li Q, Li K, Chen L, Li W, et al. (2013) Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell like traits in cancer cells. Oncogene 32: 4203-4213.
27. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, et al. (1992) Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Research and Treatment 24(2): 85-95. (Pubitemid 23063891)
28. Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, et al. (2007) Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast cancer res 9: R32.
29. Hartman ZC, Yang XY, Glass O, Lei G, Osada T, et al. (2011) HER2 overexpression elicits a pro-inflammatory autocrine IL-6 signaling loop that is critical for tumorigenesis. Cancer Res 71: 4380-4391.
30. Assimakopoulos D, Kolettas E, Patrikakos G,Evangelou A (2002) The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol. Histopathol 17: 1269-1281.
31. Bourguignon LY, Singleton PA, Zhu H, Diedrich F (2003) Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem 278: 29420-29434. (Pubitemid 36962321)
32. Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH (2005) Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65: 6516-6520.r (Pubitemid 41060685)
33. Sherry MM, Reeves A, Wu JK, Cochran BH (2009) STAT3 is required for proliferation and maintenance of multipotency of glioblastoma stem cells. Stem Cells 27: 2383-2392.
34. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, et al. (2009) Telomerase modulates Wnt signaling by associating with target chromatin. Nature 460: 66-72.
35. Huang H, Zhao W, Yang D (2012) Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells. Biochem Biophys Res Commun 418: 186-190.
36. Darnell Jr JE (1997) STATs and gene regulation. Science 277: 1630-1635.
37. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, et al. (1999) Stat3 as an oncogene. Cell 98: 295-303. (Pubitemid 29380565)
38. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, et al. (1998) STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 17: 6670-6677. (Pubitemid 28521800)